← Back to Clinical Trials
Recruiting NCT07134569

NCT07134569 Motor Function Assessment and VR-based Motor Training in Adults With Autism Spectrum Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07134569
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Autism
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2023-12-15
Primary Completion 2027-07-31

Trial Parameters

Condition Autism
Sponsor National Taiwan University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age 45 Years
Start Date 2023-12-15
Completion 2027-07-31
Interventions
VR-based motor training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if autism affect motor functions, including muscle strength, balance, and motor control? Additionally, understanding the motor functions, cognitive functions, and brain activation in individuals with autism, and verifying whether motor training can effectively improve muscle strength, balance, and motor control. The main questions aim to answer are: \[primary hypothesis or outcome measure 1\]? \[primary hypothesis or outcome measure 2\]? If there is a comparison group: Researchers will compare \[arm information\] to see if \[insert effects\]. Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].

Eligibility Criteria

\> The ASD Group Inclusion criteria: * young adult aged between 18 and 45 years who had a diagnosis of ASD from a licensed mental health or medical professional based on DSM-5. * was motivated to complete the 6-week VR-based motor function training. * had a full-scale IQ \> 70 on the WAIS-IV. Exclusion criteria: * a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis), neurological diseases (e.g., stroke, lumbar radiculopathy, or spinal cord injury) that hamper walking function, or neurosurgery. * visual impairment and/or hearing impairment that would preclude participation in motor assessment or training. * The Non-ASD control group Inclusion criteria: * young adult aged between 18 and 45 years who do not have a diagnosis of ASD. * had a full-scale IQ \> 70 on the WAIS-IV. Exclusion criteria: * a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis), neurological diseases (e.g., stroke, lumbar radicul

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology